M
Murat Inanc
Researcher at Istanbul University
Publications - 68
Citations - 11186
Murat Inanc is an academic researcher from Istanbul University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 19, co-authored 20 publications receiving 8996 citations. Previous affiliations of Murat Inanc include University College London & University of Pisa.
Papers
More filters
Journal ArticleDOI
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Michelle Petri,Ana Maria Orbai,Graciela S. Alarcón,Caroline Gordon,Joan T. Merrill,Paul R. Fortin,Ian N. Bruce,David A. Isenberg,Daniel J. Wallace,Ola Nived,Gunnar Sturfelt,Rosalind Ramsey-Goldman,Sang Cheol Bae,John G. Hanly,Jorge Sanchez-Guerrero,Ann E. Clarke,Cynthia Aranow,Susan Manzi,Murray B. Urowitz,Dafna D. Gladman,Kenneth C. Kalunian,Melissa Costner,Victoria P. Werth,Asad Zoma,Sasha Bernatsky,Guillermo Ruiz-Irastorza,Munther A. Khamashta,Søren Jacobsen,Jill P. Buyon,Peter J. Maddison,Mary Anne Dooley,Ronald F van Vollenhoven,Ellen M. Ginzler,Thomas Stoll,Christine A. Peschken,Joseph L. Jorizzo,Jeffrey P. Callen,S. Sam Lim,Barri J. Fessler,Murat Inanc,Diane L. Kamen,Anisur Rahman,Kristjan Steinsson,Andrew G. Franks,Lisa Sigler,Suhail Hameed,Hong Fang,Ngoc Minh Pham,Robin L. Brey,Michael H. Weisman,Gerald McGwin,Laurence S. Magder +51 more
TL;DR: The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet stringent methodology requirements, and incorporate new knowledge regarding the immunology of SLE.
Journal ArticleDOI
2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative
Frank H J van den Hoogen,Dinesh Khanna,Jaap Fransen,Sindhu R Johnson,Murray Baron,Alan Tyndall,Marco Matucci-Cerinic,Raymond P. Naden,Thomas A. Medsger,Patricia Carreira,Gabriela Riemekasten,Philip J. Clements,Christopher P. Denton,Oliver Distler,Yannick Allanore,Daniel E. Furst,Armando Gabrielli,Maureen D. Mayes,Jacob M van Laar,James R. Seibold,László Czirják,Virginia D. Steen,Murat Inanc,Otylia Kowal-Bielecka,Ulf Müller-Ladner,Gabriele Valentini,Douglas J. Veale,Madelon C. Vonk,Ulrich A Walker,Lorinda Chung,David H. Collier,David H. Collier,Mary Ellen Csuka,Barri J. Fessler,Serena Guiducci,Ariane L. Herrick,Vivien Hsu,Sergio A. Jimenez,Bashar Kahaleh,Bashar Kahaleh,Peter A. Merkel,Stanislav Sierakowski,Richard M. Silver,Robert W. Simms,Robert W. Simms,John Varga,Janet E. Pope +46 more
TL;DR: The ACR/EULAR classification criteria for SSc performed better than the 1980 ACR criteria and should allow for more patients to be classified correctly as having the disease.
Journal ArticleDOI
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank H J van den Hoogen,Dinesh Khanna,Jaap Fransen,Sindhu R Johnson,Murray Baron,Alan Tyndall,Marco Matucci-Cerinic,Raymond P. Naden,Thomas A. Medsger,Patricia Carreira,Gabriela Riemekasten,Philip J. Clements,Christopher P. Denton,Oliver Distler,Yannick Allanore,Daniel E. Furst,Armando Gabrielli,Maureen D. Mayes,Jacob M van Laar,James R. Seibold,László Czirják,Virginia D. Steen,Murat Inanc,Otylia Kowal-Bielecka,Ulf Müller-Ladner,Gabriele Valentini,Douglas J. Veale,Madelon C. Vonk,Ulrich A Walker,Lorinda Chung,David H. Collier,David H. Collier,Mary Ellen Csuka,Barri J. Fessler,Serena Guiducci,Ariane L. Herrick,Ariane L. Herrick,Vivien Hsu,Sergio A. Jimenez,Bashar Kahaleh,Peter A. Merkel,Peter A. Merkel,Stanislav Sierakowski,Richard M. Silver,Robert W. Simms,John Varga,Janet E. Pope +46 more
TL;DR: The ACR/EULAR classification criteria for SSc performed better than the 1980 ACR criteria and should allow for more patients to be classified correctly as having the disease.
Journal ArticleDOI
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
Ronald F. van Vollenhoven,Marta Mosca,George Bertsias,David A. Isenberg,Annegret Kuhn,Kristen Lerstrom,Martin Aringer,Hendrika Bootsma,Dimitrios T. Boumpas,Ian N. Bruce,Ricard Cervera,Ann E. Clarke,Nathalie Costedoat-Chalumeau,László Czirják,Ronald H. W. M. Derksen,Thomas Dörner,Caroline Gordon,Winfried Graninger,Frédéric Houssiau,Murat Inanc,Søren Jacobsen,David Jayne,A. Jedryka-Goral,A. Levitsky,Roger A. Levy,Xavier Mariette,Eric F Morand,Sandra V. Navarra,Irmgard Neumann,Anisur Rahman,Jozef Rovensky,Josef S Smolen,Carlos Vasconcelos,Alexandre E. Voskuyl,Anne Voss,Helena Zakharova,Asad Zoma,Matthias Schneider +37 more
TL;DR: Treating-to-target-in-SLE (T2T/SLE) recommendations were developed by a large task force of multispecialty experts and a patient representative and it is anticipated that ‘treating- to-target’ can and will be applicable to the care of patients with SLE.
Journal ArticleDOI
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Ian N. Bruce,Aidan G. O'Keeffe,Vernon T. Farewell,John G. Hanly,Susan Manzi,Li Su,Dafna D. Gladman,Sang Cheol Bae,Jorge Sanchez-Guerrero,Juanita Romero-Diaz,Caroline Gordon,Daniel J. Wallace,Ann E. Clarke,Sasha Bernatsky,Ellen M. Ginzler,David A. Isenberg,Anisur Rahman,J. T. Merrill,Graciela S. Alarcón,Barri J. Fessler,Paul R. Fortin,Michelle Petri,Kristjan Steinsson,Mary Anne Dooley,Munther A. Khamashta,Rosalind Ramsey-Goldman,Asad Zoma,Gunnar Sturfelt,Ola Nived,Cynthia Aranow,Meggan Mackay,Manuel Ramos-Casals,Ronald F van Vollenhoven,Kenneth C. Kalunian,Guillermo Ruiz-Irastorza,S. Sam Lim,Diane L. Kamen,Christine A. Peschken,Murat Inanc,Murray B. Urowitz +39 more
TL;DR: It is found that several potentially modifiable risk factors for damage accrual are identified and an integrated strategy to address these may improve long-term outcomes.